Mary Beckerle, CEO and director of Huntsman Cancer Institute at the University of Utah, is this year’s recipient of the Alfred G. Knudson Award in Cancer Genetics from the NCI.
The award is named after Alfred G. Knudson, a physician and researcher whose work added major insights to the understanding of the genetic basis of cancer. The award is presented by the NCI each year to a scientist who has made significant research contributions to the field of cancer genetics.
Beckerle will receive the award and present the award lecture, “Interface Between Cytoskeletal Dynamics and Tumor Biology” at NCI.
Beckerle’s research has discovered a new pathway that is critical for the ability of cells to respond to mechanical signals in their environment. Such signals are now known to regulate cell growth and movement, two behaviors that are critically important in tumor biology.
Her lab is currently focused on understanding the impact of this pathway on tumor progression, particularly in Ewing sarcoma, a rare but deadly bone cancer that typically affects children and young adults.
In addition to leading HCI, Beckerle is a distinguished professor of biology and oncological sciences and holds the Jon M. Huntsman Presidential Endowed Chair at the University of Utah.
Beckerle was appointed as a member of Vice President Biden’s Cancer Moonshot Blue Ribbon Panel where she co-chaired the working group on Precision Prevention and Early Detection. Beckerle is an elected Fellow of the American Academy of Arts and Sciences and the American Philosophical Society.
Beckerle is the 22nd Knudson award winner. Past recipients of the award include Nobel laureates J. Michael Bishop, Robert Horvitz, Harold Varmus, Leland Hartwell, and Elizabeth H. Blackburn.
